Skip to main content

Table 7 Doctors’ office visits, emergency department visits, and overnight hospital admissions due to hypoparathyroidism at baselinea

From: The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

Parameter, n (%)

rhPTH(1-84)

(n=60)

Conventional therapy

(n=571)

Analysis populationb

(N=631)

Number of doctors’ office visits

 

 0

8 (13.3)

123 (21.5)

131 (20.8)

 1

5 (8.3)

82 (14.4)

87 (13.8)

 2–3

20 (33.3)

148 (25.9)

168 (26.6)

 4–5

6 (10.0)

42 (7.4)

48 (7.6)

 6–7

3 (5.0)

18 (3.2)

21 (3.3)

 8–9

7 (11.7)

15 (2.6)

22 (3.5)

 10–12

3 (5.0)

9 (1.6)

12 (1.9)

 13–15

1 (1.7)

2 (0.4)

3 (0.5)

 ≥16

2 (3.3)

6 (1.1)

8 (1.3)

 Missing

5 (8.3)

126 (22.1)

131 (20.8)

Number of emergency department visits

 0

11 (18.3)

86 (15.1)

97 (15.4)

 1

15 (25.0)

41 (7.2)

56 (8.9)

 2–3

5 (8.3)

25 (4.4)

30 (4.8)

 4–5

3 (5.0)

6 (1.1)

9 (1.4)

 6–7

3 (5.0)

8 (1.4)

11 (1.7)

 8–9

0 (0.0)

0 (0.0)

0 (0.0)

 10–12

1 (1.7)

1 (0.2)

2 (0.3)

 13–15

0 (0.0)

1 (0.2)

1 (0.2)

 ≥16

0 (0.0)

0 (0.0)

0 (0.0)

 Missing

22 (36.7)

403 (70.6)

425 (67.4)

≥1 overnight hospital admission

27 (45.0)

83 (14.5)

110 (17.4)

  1. rhPTH(1-84) recombinant human parathyroid hormone (1-84)
  2. aData are events reported in adult patients that occurred within 12 months before baseline
  3. bBaseline is defined as the assessment at enrollment (visit 1); pediatric patients (n=27), those who received rhPTH(1-34) (n=14), and those who initiated rhPTH(1-84) before enrollment (n=65) were excluded from the analysis